Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HC Surgical SpecialistsSGX:1B1 +1.45%63 Net Margin % is 31.38% as of May. 2026, which is 3% above its 10-year median of 30.45. GuruFocus rates SGX:1B1 with a GF Score™ of 63/100 and a GF Value™ of S$0.30 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, HC Surgical Specialists ranks better than 98.52% on this metric.
The historical rank and industry rank for HC Surgical Specialists's Net Margin % or its related term are showing as below:
SGX:1B1'
s Net Margin % Range Over the Past 10 Years
Min: 13.8 Med: 30.45 Max: 44.16
Current: 36.04
SGX:1B1's Net Margin % is ranked better than 98.52% of 203
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.74
vs SGX:1B1: 36.04
HC Surgical Specialists (SGX:1B1) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
HC Surgical Specialists Net Margin % Related Terms
HC Surgical Specialists Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:1B1 vs TMO, DHR, IDXX: Net Margin % Comparison
For the Diagnostics & Research subindustry, HC Surgical Specialists's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HC Surgical Specialists Net Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, HC Surgical Specialists's Net Margin % distribution charts can be found below:
* The bar in red indicates where HC Surgical Specialists's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HC Surgical Specialists (SGX:1B1) has a Net Margin % of 31.38% as of May. 2026. Net margin is the ratio of total net income to net sales. View historical data on HC Surgical Specialists and its competitors. This is near median its historical median of 30.45. Over the past decade, HC Surgical Specialists' Net Margin % has ranged from 13.80 to 44.16. According to the industry distribution chart, HC Surgical Specialists ranks #3 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 1.5%.
Is HC Surgical Specialists' Net Margin % too high?
HC Surgical Specialists' current Net Margin % of 31.38% is near median its 10-year median of 30.45. Over the past 10 years, this metric has ranged from a low of 13.80 to a high of 44.16. Based on the distribution chart, HC Surgical Specialists ranks #3 out of 203 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, HC Surgical Specialists has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HC Surgical Specialists' Net Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, HC Surgical Specialists ranks #3 out of 203 companies for Net Margin %. This places HC Surgical Specialists in the top 2% of its industry — outperforming the majority of peers. Historically, HC Surgical Specialists' own Net Margin % has ranged from 13.80 to 44.16 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on HC Surgical Specialists and its competitors. HC Surgical Specialists's current Net Margin % is 31.38%, which is near median its own 10-year median of 30.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HC Surgical Specialists stock overvalued right now?
Based on GuruFocus' analysis, HC Surgical Specialists (SGX:1B1) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.30, compared to a current price of S$0.35 — trading 16.7% above its estimated fair value. The current Net Margin % is 31.38%, which is near median its 10-year median of 30.45. HC Surgical Specialists' overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For HC Surgical Specialists (SGX:1B1), the current Net Margin % is 31.38% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HC Surgical Specialists (SGX:1B1) Overvalued in 2026?
Based on GuruFocus' analysis, HC Surgical Specialists stock appears to be overvalued.
The current stock price of S$0.35 is trading 16.7% above its estimated GF Value™ of S$0.30.
GuruFocus considers HC Surgical Specialists to be Modestly Overvalued.
Key valuation signals for SGX:1B1:
Net Margin %: 31.38% (near median its 10-year median of 30.45)
GF Value™: S$0.30 vs. price of S$0.35 (16.7% above fair value)
No single metric tells the full story. See the SGX:1B1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HC Surgical Specialists Ltd is a medical services group. The company is engaged in providing endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services. The operating segment of the company is the healthcare segment. Geographically, it operates only in Singapore. The company has its facilities center and clinics at various places in Singapore.
63GF Score
Get the complete analysis for SGX:1B1
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:1B1 has been successfully added to your 
